Gilead Sciences - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsGilead Sciences

Gilead Sciences(GILD)

Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Atripla	Efavirenz, Emtricitabine, Tenofovir disoproxil	2006-07-12	2024-2038	Hiv infections , Hiv , Acquired immunodeficiency syndrome , Chronic hepatitis b
Biktarvy	Bictegravir, Emtricitabine, Tenofovir alafenamide	2018-02-07	2024-2038	Hiv infections , Acquired immunodeficiency syndrome , Chronic hepatitis b , Hepatitis b
Cayston	Aztreonam	2010-02-22		Respiratory tract infections , Cystic fibrosis , Urinary tract infections , Bacterial infections , Intraabdominal infections , Pseudomonas infections , Endometritis , Cellulitis
Complera	Emtricitabine, Rilpivirine, Tenofovir disoproxil	2011-08-10	2024-2038	Hiv infections, Hiv, Acquired immunodeficiency syndrome, Chronic hepatitis b
Descovy	Emtricitabine, Tenofovir alafenamide	2016-04-04	2024-2038	Hiv infections, Acquired immunodeficiency syndrome, Chronic hepatitis b, Hepatitis b
Emtriva	Emtricitabine	2003-07-02	2024-2038	Hiv infections, Hiv, Acquired immunodeficiency syndrome, Chronic hepatitis b
Epclusa	Sofosbuvir, Velpatasvir	2016-06-28	2028-2037	Hepatitis c, Chronic hepatitis c

1

2

3

4

5

>

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

respiratory tract infections

,

,

nerve degeneration

,

neuroinflammatory diseases

,

disease progression

,

acute kidney injury

,

,

acquired immunodeficiency syndrome

,

x-linked combined immunodeficiency diseases

,

coronavirus infections

,

,

communicable diseases

,

respiratory distress syndrome

,

,

,

severe acute respiratory syndrome

,

viral pneumonia

,

ebola hemorrhagic fever

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

diabetes mellitus

,

,

,

post-acute covid-19 syndrome

,

,

,

respiratory insufficiency

,

immunocompromised host

,

critical illness

,

cytokine release syndrome

,

,

,

,

,

,

,

blood coagulation disorders

,

mucocutaneous lymph node syndrome

,

hyperaldosteronism

,

pulmonary arterial hypertension

,

urinary tract infections

,

hyperphosphatemia

,

,

,

sleep initiation and maintenance disorders

,

,

cardiac arrhythmias

,

bronchopulmonary dysplasia

,

adrenal insufficiency

,

,

hemostatic disorders

,

coagulation protein disorders

,

attention deficit disorder with hyperactivity

,

iatrogenic disease

,

,

,

,

chronic kidney failure

,

,

,

,

,

hospitalization

,

Sacituzumab govitecan

,

kidney neoplasms

,

ureteral neoplasms

,

gastrointestinal neoplasms

,

,

urinary bladder neoplasms

,

invasive hydatidiform mole

,

brain neoplasms

,

urologic neoplasms

,

transitional cell carcinoma

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

uterine cervical neoplasms

,

,

ovarian epithelial carcinoma

,

ovarian neoplasms

,

renal cell carcinoma

,

pancreatic neoplasms

,

hepatocellular carcinoma

,

esophageal neoplasms

,

squamous cell carcinoma of head and neck

,

liver neoplasms

,

small cell lung carcinoma

,

,

salivary gland neoplasms

,

male breast neoplasms

,

thyroid neoplasms

,

anaplastic thyroid carcinoma

,

thyroid diseases

,

,

thymus neoplasms

,

squamous cell carcinoma

,

esophageal squamous cell carcinoma

,

neoplasm metastasis

,

malignant mesothelioma

,

,

,

breast neoplasms

,

triple negative breast neoplasms

,

non-small-cell lung carcinoma

,

,

endometrial neoplasms

,

Tenofovir alafenamide

insulin resistance

,

autoimmune diseases of the nervous system

,

,

nervous system malformations

,

kidney diseases

,

,

,

chronic hepatitis d

,

,

herpesviridae infections

,

,

patient acceptance of health care

,

multiple sclerosis

,

,

relapsing-remitting multiple sclerosis

,

,

drug-related side effects and adverse reactions

,

leukoencephalopathies

,

progressive multifocal leukoencephalopathy

,

hepatitis b virus

,

,

,

,

treatment adherence and compliance

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

,

,

chronic hepatitis b

,

,

acquired immunodeficiency syndrome

,

chronic hepatitis

,

,

immunologic deficiency syndromes

,

communicable diseases

,

,

,

medication adherence

,

,

substance-related disorders

,

,

healthy volunteers/patients

,

chronic renal insufficiency

,

renal insufficiency

,

,

persistent infection

,

cognitive dysfunction

,

chronic hepatitis c

,

patient compliance

,

,

,

,

kidney transplantation

,

non-hodgkin lymphoma

,

burkitt lymphoma

,

,

,

neurocognitive disorders

,

sleep wake disorders

,

,

,

,

anxiety disorders

,

metabolic diseases

,

opioid-related disorders

,

metabolic bone diseases

,

,

morphine dependence

,

,

,

hiv seropositivity

,

,

liver cirrhosis

,

,

biliary liver cirrhosis

,

pancreatic neoplasms

,

primary myelofibrosis

,

multiple myeloma

,

,

plasma cell neoplasms

,

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

breast neoplasms

,

myeloproliferative disorders

,

bcr-abl positive chronic myelogenous leukemia

,

leukemia myeloid chronic atypical bcr-abl negative

,

myelodysplastic-myeloproliferative diseases

,

myeloid leukemia chronic-phase

,

myeloid leukemia accelerated phase

,

,

,

,

pancreatic ductal carcinoma

,

essential thrombocythemia

,

polycythemia vera

,

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

allergic rhinitis

,

,

b-cell lymphoma

,

,

waldenstrom macroglobulinemia

,

mantle-cell lymphoma

,

b-cell lymphoma marginal zone

,

hematologic neoplasms

,

myeloid leukemia acute

,

precursor cell lymphoblastic leukemia-lymphoma

,

large b-cell lymphoma diffuse

,

myeloid leukemia

,

myelodysplastic syndromes

,

myelomonocytic leukemia chronic

,

hodgkin disease

,

neoplasm metastasis

,

myelomonocytic leukemia juvenile

,

non-small-cell lung carcinoma

,

,

prolymphocytic leukemia

,

,

reactive arthritis

,

colorectal neoplasms

,

b-cell chronic lymphocytic leukemia

,

,

lymphoid leukemia

,

non-hodgkin lymphoma

,

follicular lymphoma

,

,

,

thrombocytopenia

,

,

,

digestive signs and symptoms

lung transplantation

,

,

chronic hepatitis

,

chronic kidney failure

,

,

,

chronic hepatitis b

,

blood coagulation disorders

,

hemostatic disorders

,

renal insufficiency

,

,

,

portal hypertension

,

hepatocellular carcinoma

,

liver neoplasms

,

herpesviridae infections

,

,

porphyria cutanea tarda

,

erythropoietic porphyria

,

,

hepatic porphyrias

,

sickle cell anemia

,

,

,

,

acquired immunodeficiency syndrome

,

,

liver cirrhosis

,

immunologic deficiency syndromes

,

cryoglobulinemia

,

,

,

,

,

chronic hepatitis c

,

,

communicable diseases

,

,

,

opioid-related disorders

,

metabolic diseases

,

metabolic bone diseases

,

,

morphine dependence

,

,

,

chronic obstructive pulmonary disease

,

,

interstitial lung diseases

,

autoimmune diseases

,

infectious pregnancy complications

,

recreational drug use

,

pregnancy complications

,

medication adherence

,

,

,

,

insulin resistance

,

pharmacokinetics

,

neoplasm metastasis

,

,

latent tuberculosis

,

long qt syndrome

,

pharmacological phenomena

,

pancreatic ductal carcinoma

,

pancreatic neoplasms

,

,

,

coronavirus infections

,

,

,

viral pneumonia

,

,

falciparum malaria

,

,

myeloid leukemia acute

,

precursor cell lymphoblastic leukemia-lymphoma

,

biphenotypic leukemia acute

,

,

immunologic deficiency syndromes

,

,

,

,

,

renal insufficiency

,

,

pneumocystis pneumonia

,

,

acquired immunodeficiency syndrome

,

,

,

healthy volunteers/patients

,

communicable diseases

,

,

,

,

,

,

chronic hepatitis c

,

,

,

neurotoxicity syndromes

,

drug-related side effects and adverse reactions

,

non-small-cell lung carcinoma

,

drug interactions

,

metabolic diseases

,

opioid-related disorders

,

metabolic bone diseases

,

morphine dependence

,

sleep wake disorders

,

,

,

,

immunosuppression therapy

,

cognitive dysfunction

,

neurocognitive disorders

,

patient compliance

,

,

cardiovascular diseases

,

congenital abnormalities

,

,

vascular diseases

,

,

hiv-associated lipodystrophy syndrome

,

body weight changes

,

cardiovascular abnormalities

,

hiv seropositivity

,

aids dementia complex

,

,

drug resistance

,

respiratory insufficiency

,

,

,

acute kidney injury

,

chronic hepatitis b

,

,

sexually transmitted diseases

,

cystic fibrosis

,

pseudomonas aeruginosa

,

,

,

communicable diseases

,

respiratory aspiration

,

respiratory tract infections

,

burkholderia infections

,

,

pseudomonas infections

,

bronchiolitis obliterans

,

,

bronchiolitis obliterans syndrome

insulin resistance

,

heart disease risk factors

,

lipid metabolism disorders

,

,

alzheimer disease

,

,

gender identity

,

behavior and behavior mechanisms

,

,

biliary liver cirrhosis

,

,

,

aids-related lymphoma

,

pulmonary tuberculosis

,

leukoencephalopathies

,

progressive multifocal leukoencephalopathy

,

,

autoimmune diseases of the nervous system

,

nervous system malformations

,

drug-related side effects and adverse reactions

,

htlv-ii infections

,

amphetamine-related disorders

,

,

hepatitis b virus

,

disease progression

,

patient acceptance of health care

,

multiple sclerosis

,

post-acute covid-19 syndrome

,

chronic hepatitis

,

,

,

,

antibiotic prophylaxis

,

coronavirus infections

,

,

treatment adherence and compliance

,

,

severe acute respiratory syndrome

,

metabolic syndrome

,

,

,

,

acquired immunodeficiency syndrome

,

,

communicable diseases

,

,

immunologic deficiency syndromes

,

,

,

,

chronic hepatitis b

,

healthy volunteers/patients

,

,

medication adherence

,

,

,

sexually transmitted diseases

,

,

,

hiv seropositivity

,

chronic hepatitis c

,

substance-related disorders

,

cognitive dysfunction

,

,

,

patient compliance

,

highly active antiretroviral therapy

,

renal insufficiency

,

,

hiv seronegativity

,

metabolic bone diseases

,

cardiovascular diseases

,

,

metabolic diseases

,

,

neurocognitive disorders

,

neurotoxicity syndromes

,

recreational drug use

,

drug interactions

,

,

,

opioid-related disorders

,

,

,

,

,

,

,

,

epstein-barr virus infections

,

,

,

,

,

,

body weight changes

,

persistent infection

,

morphine dependence

,

organ transplantation

,

sleep wake disorders

,

,

,

anxiety disorders

,

,

,

hormone replacement therapy

,

kidney transplantation

,

sexual behavior

,

papillomaviridae

,

cytomegalovirus infections

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

atherosclerosis

,

immunosuppression therapy

,

,

,

physiologic calcification

,

pathologic bone demineralization

,

aids-related opportunistic infections

,

opportunistic infections

,

chronic renal insufficiency

,

,

non-alcoholic fatty liver disease

,

,

drug resistance

,

,

female genital diseases

,

genital diseases

,

sustained virologic response

,

,

immune reconstitution inflammatory syndrome

,

,

,

contraception behavior

,

combination drug therapy

,

acute kidney injury

,

,

,

high-risk pregnancy

,

liver transplantation

,

pharmacokinetics

,

,

,

liver cirrhosis

,

adolescent behavior

,

intravenous substance abuse

,

genetic linkage

,

risk reduction behavior

,

viral hepatitis human

,

,

bacterial sexually transmitted diseases

,

chlamydia infections

,

rna virus infections

,

viral sexually transmitted diseases

,

blood-borne infections

,

,

Adefovir dipivoxil

,

,

liver transplantation

,

chronic hepatitis

,

,

,

,

chronic hepatitis b

,

acquired immunodeficiency syndrome

Tenofovir disoproxil

insulin resistance

,

heart disease risk factors

,

lipid metabolism disorders

,

contraception behavior

,

gender dysphoria

,

,

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

parkinson disease

,

gender identity

,

behavior and behavior mechanisms

,

,

biliary liver cirrhosis

,

pharmacokinetics

,

,

multiple sclerosis

,

ebola hemorrhagic fever

,

,

aids-related lymphoma

,

pulmonary tuberculosis

,

leukoencephalopathies

,

progressive multifocal leukoencephalopathy

,

,

autoimmune diseases of the nervous system

,

nervous system malformations

,

htlv-ii infections

,

amphetamine-related disorders

,

,

b-cell chronic lymphocytic leukemia

,

large b-cell lymphoma diffuse

,

lymphoid leukemia

,

nutrition disorders

,

,

relapsing-remitting multiple sclerosis

,

lung transplantation

,

patient acceptance of health care

,

post-acute covid-19 syndrome

,

,

,

chronic hepatitis d

,

disease progression

,

liver transplantation

,

coronavirus infections

,

b-cell lymphoma

,

metabolic syndrome

,

hyperlipidemias

,

,

antibiotic prophylaxis

,

,

severe acute respiratory syndrome

,

treatment adherence and compliance

,

,

,

,

,

,

,

,

chronic hepatitis b

,

,

acquired immunodeficiency syndrome

,

,

chronic hepatitis

,

communicable diseases

,

healthy volunteers/patients

,

immunologic deficiency syndromes

,

,

,

,

,

,

herpesviridae infections

,

sexually transmitted diseases

,

medication adherence

,

liver cirrhosis

,

,

renal insufficiency

,

,

hepatocellular carcinoma

,

liver neoplasms

,

hepatitis b virus

,

chronic hepatitis c

,

cardiovascular diseases

,

,

hiv seropositivity

,

,

,

,

,

,

,

highly active antiretroviral therapy

,

,

,

,

substance-related disorders

,

end stage liver disease

,

,

acute-on-chronic liver failure

,

,

drug interactions

,

metabolic bone diseases

,

persistent infection

,

hiv seronegativity

,

patient compliance

,

chronic renal insufficiency

,

metabolic diseases

,

,

hepatic insufficiency

,

kidney diseases

,

non-alcoholic fatty liver disease

,

,

cognitive dysfunction

,

,

,

,

neurotoxicity syndromes

,

hiv-associated lipodystrophy syndrome

,

bacterial sexually transmitted diseases

,

,

drug-related side effects and adverse reactions

,

body weight changes

,

non-hodgkin lymphoma

,

,

opioid-related disorders

,

,

,

neurocognitive disorders

,

,

,

epstein-barr virus infections

,

recreational drug use

,

physiologic calcification

,

pathologic bone demineralization

,

,

,

congenital abnormalities

,

,

morphine dependence

,

organ transplantation

,

sleep wake disorders

,

,

,

anxiety disorders

,

central nervous system diseases

,

nervous system diseases

,

,

hormone replacement therapy

,

kidney transplantation

,

sexual behavior

,

papillomaviridae

,

cytomegalovirus infections

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

atherosclerosis

,

immunosuppression therapy

,

,

aids-related opportunistic infections

,

opportunistic infections

,

vascular diseases

,

cardiovascular abnormalities

,

burkitt lymphoma

,

,

,

vitamin d deficiency

,

,

drug resistance

,

hematologic neoplasms

,

hematologic diseases

,

,

risk reduction behavior

,

,

,

sustained virologic response

,

acute kidney injury

,

,

portal hypertension

,

esophageal and gastric varices

,

,

female genital diseases

,

genital diseases

,

,

,

chemical and drug induced liver injury

,

immune reconstitution inflammatory syndrome

,

,

,

combination drug therapy

,

,

,

high-risk pregnancy

,

,

,

,

adolescent behavior

,

,

,

intravenous substance abuse

,

platelet aggregation

,

chronic kidney failure

,

renal tubular acidosis

,

retinal diseases

,

,

focal segmental glomerulosclerosis

,

hypercholesterolemia

,

hypertriglyceridemia

,

genetic linkage

,

,

patient satisfaction

,

viral hepatitis human

,

papillomavirus infections

,

,

chlamydia infections

,

rna virus infections

,

viral sexually transmitted diseases

,

blood-borne infections

,

perinatal mortality

pharmacokinetics

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

substance-related disorders

,

neoplasm metastasis

,

alzheimer disease

,

non-hodgkin lymphoma

,

premature obstetric labor

,

hyperlipidemias

,

hyperlipoproteinemias

,

,

pharmacological phenomena

,

,

,

hepatic insufficiency

,

hiv seronegativity

,

,

non-small-cell lung carcinoma

,

drug-related side effects and adverse reactions

,

,

,

,

pulmonary tuberculosis

,

,

pancreatic neoplasms

,

prostatic neoplasms

,

aids-related lymphoma

,

breast neoplasms

,

triple negative breast neoplasms

,

disease progression

,

,

,

chronic hepatitis

,

,

acquired immunodeficiency syndrome

,

,

,

,

communicable diseases

,

healthy volunteers/patients

,

immunologic deficiency syndromes

,

,

,

,

,

,

drug interactions

,

,

chronic hepatitis c

,

,

,

,

,

cognitive dysfunction

,

neurocognitive disorders

,

,

sleep wake disorders

,

cardiovascular diseases

,

,

,

,

hiv seropositivity

,

,

hypercholesterolemia

,

,

mitochondrial diseases

,

recreational drug use

,

falciparum malaria

,

metabolic syndrome

,

,

,

anxiety disorders

,

central nervous system diseases

,

nervous system diseases

,

,

cryptococcal meningitis

,

highly active antiretroviral therapy

,

,

hiv-associated lipodystrophy syndrome

,

,

chronic hepatitis b

,

penicillium chrysogenum

,

biological availability

,

,

contraception behavior

,

sustained virologic response

,

neurobehavioral manifestations

,

medication adherence

,

,

,

attempted suicide

,

,

neurotoxicity syndromes

,

,

chemical and drug induced liver injury

,

cd4 lymphocyte count

,

immune reconstitution inflammatory syndrome

,

heart disease risk factors

,

meningeal tuberculosis

,

hypersensitivity

,

drug hypersensitivity

,

congenital abnormalities

,

,

neural tube defects

,

spinal dysraphism

acquired immunodeficiency syndrome

,

,

communicable diseases

,

immunologic deficiency syndromes

,

,

,

,

,

patient satisfaction

,

patient acceptance of health care

,

patient preference

renal insufficiency

,

,

chronic hepatitis b

,

,

,

,

,

chronic hepatitis d

,

chronic hepatitis

,

,

,

liver cirrhosis

,

,

portal hypertension

,

communicable diseases

,

,

Axicabtagene ciloleucel

non-hodgkin lymphoma

,

cytokine release syndrome

,

neurotoxicity syndromes

,

,

b-cell lymphoma marginal zone

,

mantle-cell lymphoma

,

hematologic neoplasms

,

,

b-cell lymphoma

,

large b-cell lymphoma diffuse

,

follicular lymphoma

1

2

3

4

5

6

...

15

>

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use